See more : Sun Create Electronics Co., Ltd (600990.SS) Income Statement Analysis – Financial Results
Complete financial analysis of SonoScape Medical Corp. (300633.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SonoScape Medical Corp., a leading company in the Medical – Devices industry within the Healthcare sector.
- Luboa Group, Inc. (LBAO) Income Statement Analysis – Financial Results
- Argus (Shanghai) Textile Chemicals Co.,Ltd. (603790.SS) Income Statement Analysis – Financial Results
- Integra Engineering India Limited (INTEGRAEN.BO) Income Statement Analysis – Financial Results
- Amiyaki Tei Co., Ltd. (2753.T) Income Statement Analysis – Financial Results
- Pick-Ups Plus, Inc. (PUPS) Income Statement Analysis – Financial Results
SonoScape Medical Corp. (300633.SZ)
About SonoScape Medical Corp.
SonoScape Medical Corp. develops and manufactures medical equipment in China and internationally. The company offers ultrasound diagnostic systems, such as trolley color Doppler, portable color Doppler, B/W ultrasound, and veterinary ultrasound equipment; and endoscopy equipment, such as image processors, light sources, and gastroenterology products. It also provides technical and spare parts support, training, upgradation, and field services. SonoScape Medical Corp. was founded in 2002 and is based in Shenzhen, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.12B | 1.76B | 1.44B | 1.16B | 1.25B | 1.23B | 989.07M | 719.36M | 685.83M | 639.72M | 592.24M | 484.25M |
| Cost of Revenue | 648.55M | 584.04M | 471.21M | 390.27M | 435.28M | 369.60M | 313.29M | 251.83M | 255.08M | 235.77M | 231.57M | 209.14M |
| Gross Profit | 1.47B | 1.18B | 973.39M | 772.81M | 818.58M | 857.25M | 675.78M | 467.53M | 430.75M | 403.96M | 360.68M | 275.10M |
| Gross Profit Ratio | 69.41% | 66.87% | 67.38% | 66.45% | 65.28% | 69.87% | 68.32% | 64.99% | 62.81% | 63.15% | 60.90% | 56.81% |
| Research & Development | 384.26M | 328.96M | 263.06M | 237.42M | 254.91M | 233.49M | 176.93M | 133.80M | 124.14M | 91.65M | 71.43M | 0.00 |
| General & Administrative | 29.42M | 23.51M | 26.75M | 20.88M | 22.81M | 19.60M | 21.72M | 16.28M | 14.14M | 6.19M | 4.94M | 52.64M |
| Selling & Marketing | 524.36M | 423.16M | 366.53M | 324.38M | 406.88M | 352.23M | 269.09M | 197.05M | 179.96M | 147.76M | 110.15M | 92.80M |
| SG&A | 551.23M | 446.67M | 393.28M | 345.26M | 429.69M | 371.83M | 290.81M | 213.33M | 194.11M | 153.95M | 115.09M | 145.44M |
| Other Expenses | -35.67M | -3.37M | 38.52M | -1.90M | 1.27M | -562.67K | -14.40K | 61.33M | 42.49M | 25.71M | 30.25M | 23.46M |
| Operating Expenses | 996.88M | 770.59M | 654.23M | 571.10M | 680.08M | 581.18M | 452.58M | 379.40M | 349.25M | 272.70M | 212.29M | 149.75M |
| Cost & Expenses | 1.65B | 1.35B | 1.13B | 961.37M | 1.12B | 950.78M | 765.87M | 631.22M | 604.33M | 508.47M | 443.86M | 358.90M |
| Interest Income | 46.67M | 17.84M | 5.83M | 2.38M | 1.61M | 265.26K | 2.92M | 2.55M | 1.06M | 1.10M | 660.63K | 0.00 |
| Interest Expense | 8.83M | 3.70M | 5.55M | 17.54M | 16.18M | 2.57M | 2.22M | 3.36M | 4.06M | 6.57M | 6.41M | 0.00 |
| Depreciation & Amortization | 66.03M | 57.51M | 57.82M | 33.29M | 29.17M | 22.22M | 17.18M | 18.22M | 14.10M | 11.73M | 10.32M | 4.77M |
| EBITDA | 544.92M | 439.01M | 319.94M | 8.76M | 154.65M | 293.12M | 224.98M | 162.87M | 140.38M | 138.38M | 104.70M | 130.12M |
| EBITDA Ratio | 25.70% | 28.42% | 29.05% | 20.50% | 14.69% | 26.01% | 24.56% | 24.47% | 20.71% | 26.36% | 31.70% | 26.93% |
| Operating Income | 474.81M | 382.43M | 215.66M | -44.17M | 106.62M | 271.73M | 207.68M | 79.21M | 75.93M | 120.01M | 57.72M | 127.36M |
| Operating Income Ratio | 22.39% | 21.70% | 14.93% | -3.80% | 8.50% | 22.15% | 21.00% | 11.01% | 11.07% | 18.76% | 9.75% | 26.30% |
| Total Other Income/Expenses | -983.51K | -485.92K | 38.55M | -366.42K | 1.08M | -371.31K | -14.40K | 61.33M | 42.49M | 25.71M | 30.25M | 23.46M |
| Income Before Tax | 473.83M | 381.94M | 254.21M | -44.54M | 107.69M | 271.35M | 207.66M | 140.54M | 118.42M | 145.72M | 87.97M | 150.82M |
| Income Before Tax Ratio | 22.35% | 21.67% | 17.60% | -3.83% | 8.59% | 22.12% | 21.00% | 19.54% | 17.27% | 22.78% | 14.85% | 31.14% |
| Income Tax Expense | 19.39M | 12.13M | 6.97M | 1.72M | 6.15M | 18.73M | 17.64M | 10.11M | 12.54M | 13.97M | 17.32M | 20.88M |
| Net Income | 454.44M | 369.81M | 247.24M | -46.26M | 101.54M | 252.62M | 190.02M | 130.43M | 105.87M | 131.75M | 70.65M | 129.94M |
| Net Income Ratio | 21.43% | 20.98% | 17.12% | -3.98% | 8.10% | 20.59% | 19.21% | 18.13% | 15.44% | 20.60% | 11.93% | 26.83% |
| EPS | 1.06 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 | 0.49 | 0.36 | 0.29 | 0.37 | 1.41 | 0.00 |
| EPS Diluted | 1.05 | 0.86 | 0.62 | -0.12 | 0.25 | 0.63 | 0.49 | 0.36 | 0.29 | 0.37 | 1.41 | 0.00 |
| Weighted Avg Shares Out | 428.71M | 427.86M | 400.01M | 400.01M | 400.01M | 400.01M | 387.80M | 362.30M | 365.07M | 356.09M | 0.00 | 0.00 |
| Weighted Avg Shares Out (Dil) | 432.80M | 427.86M | 400.01M | 400.01M | 400.01M | 400.99M | 387.80M | 362.30M | 365.07M | 356.09M | 0.00 | 0.00 |
Source: https://incomestatements.info
Category: Stock Reports